Clinical trial
Glutamine Supplement in MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) Syndrome in Order to Prevent Neurological Damage.
NCT04948138 is registered in ClinicalTrials.gov with Jesús González de la Aleja Tejera as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glutamine Supplement in MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) Syndrome in Order to Prevent Neurological Damage.
- Lead sponsor
- Jesús González de la Aleja Tejera
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 28, 2021
- Completion date
- October 6, 2021
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.